Genomics

To be useful in clinical development, proper infrastructure and expertise are required to harness the power of these large, real-world data sets. ICON has the capabilities and innovative technologies to deliver these initiatives through:

• Data management, visualisation and analysis with ICONIK Informatics Hub
• Collaborations with high-performance diagnostic providers Empire Genomics and Cancer Genetics, Inc.
• ICON’s dedicated Medical Device and Diagnostics Research group
• FIRECREST eConsent and FIRECREST Patient Portal for enhanced patient consent, recruitment and retention
• Direct EMR-based and real-time analytics for feasibility and protocol optimisation
• Real World Evidence strategy and analytics expertise

ICON Genomics capabilities include:

• Sampling requirements
• Sample/econsent tracking and reconciliation
• Genomic Speciality Labs
• Genome Sequencing and Sample management.
• Data Management and genome Curation capabilities.
• Clinical Trials Management
• Database Development/ Database Mining
• Technology and Business Model Innovation
• Genomic Statistical Analysis
• Analysis and reporting of Genomic results and regulatory submissions and labelling

ICON can support clients with:

• Identification of novel drug targets
• Precision Medicine (see blog post)
• Validate drug targets – Indication relationships
• Assay Development and Validation
• Biomarker Development
• Identification of disease indications